Basic Information
| LncRNA/CircRNA Name | FER1L4 |
| Synonyms | FER1L4, C20orf124 |
| Region | GRCh38_20:35558737-35607562 |
| Ensemble | ENSG00000088340 |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | osteosarcoma |
| ICD-0-3 | NA |
| Methods | qPCR etc. |
| Sample | osteosarcoma tissues |
| Expression Pattern | down-regulated |
| Function Description | LncRNA FER1L4 expression was decreased in osteosarcoma samples. LncRNA FER1L4 was not related to the gender and age of patients, but was significantly associated with disease stage, metastasis, and tumor differentiation.Low-expression of lncRNA FER1L4 might be a prognostic marker in osteosarcoma. |
| Pubmed ID | 29762833 |
| Year | 2018 |
| Title | Low-expression of lncRNA FER1L4 might be a prognostic marker in osteosarcoma. |
External Links
| Links for FER1L4 | GenBank HGNC NONCODE |
| Links for osteosarcoma | OMIM COSMIC |